A platform for analyzing immune-mediated diseases and data management.
Official title: THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT) - Immune- Mediated Diseases
NIH-10896890 · Data updated 2026-11-12
This study is working to make a helpful database for researchers studying immune-related diseases, so they can gather and share important health information more easily, which could eventually lead to better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2023 |
| Award (this year) | $587,693 |
| NIH project number | 316201200036W-P00003-759302200001-2 |
| Project ID | NIH-10896890 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by immune-mediated diseases who may benefit from enhanced data-driven insights into their conditions.
✕Less likely to help
Patients with non-immune-mediated conditions are unlikely to receive direct benefits from this research.
What this research studies
This research focuses on enhancing the Immune-Mediated Diseases Database, known as ImmPort, which provides vital bioinformatics support for biodefense immunology research. It aims to improve methods for collecting, storing, and sharing clinical data, ensuring that researchers have access to high-quality information. The project will also develop new tools for data integration and retrieval, making it easier for scientists to analyze immune responses and related conditions. Patients may benefit indirectly as this research could lead to better understanding and treatment of immune-mediated diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and management strategies for patients with immune-mediated diseases.
How similar studies have gone: Previous research has shown success in utilizing bioinformatics platforms for analyzing immune responses, indicating that this approach has potential.
Where this research is happening
Dulles, United States
Researchers
- Principal investigator: Butte, Atul
- Study coordinator: Butte, Atul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.